Guido Cavaletti
Researcher Next ID · RN-035303
Researcher · Medicine
Barcelona, Spain
- Works count
- 800
- Citation count
- 25,710
- H-index
- 86
- i10-index
- 336
Research interests
Publications
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe
Annals of Oncology · 2022 · https://doi.org/10.1016/j.annonc.2022.07.1941
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.07.003
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.01399
Regional variation of Guillain-Barré syndrome
Brain · 2018 · https://doi.org/10.1093/brain/awy232
Interventions for preventing neuropathy caused by cisplatin and related compounds
Cochrane Database of Systematic Reviews · 2014 · https://doi.org/10.1002/14651858.cd005228.pub4
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.54.0914
Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
Neuro-Oncology · 2012 · https://doi.org/10.1093/neuonc/nos203
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
The Lancet Neurology · 2012 · https://doi.org/10.1016/s1474-4422(12)70093-5
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds329
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Critical Reviews in Oncology/Hematology · 2011 · https://doi.org/10.1016/j.critrevonc.2011.04.012
Chemotherapy-induced peripheral neurotoxicity
Nature Reviews Neurology · 2010 · https://doi.org/10.1038/nrneurol.2010.160
Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
European Journal of Cancer · 2010 · https://doi.org/10.1016/j.ejca.2009.12.008
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy‐induced peripheral neurotoxicity: comparison with the National Cancer Institute‐Common Toxicity Scale
Journal of the Peripheral Nervous System · 2007 · https://doi.org/10.1111/j.1529-8027.2007.00141.x
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
Experimental Neurology · 2007 · https://doi.org/10.1016/j.expneurol.2006.11.010
Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat
European Journal of Cancer · 2001 · https://doi.org/10.1016/s0959-8049(01)00300-8
Frequency and clinical correlates of anti–neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy
Annals of Neurology · 1994 · https://doi.org/10.1002/ana.410360313
Current projects
No projects listed.